#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Familial amyotrophic lateral sclerosis Hepatocellular carcinoma Brain injury Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Nephropathy Isodicentric chromosome 15 syndrome Primary amyloidosis Peritoneal mesothelioma malignant Non-small cell lung cancer recurrent Waldenstrom's macroglobulinaemia recurrent Infantile apnoea Small intestine leiomyosarcoma Colitis ulcerative Adrenogenital syndrome Metastatic gastric cancer More trials…

    Learn about Rare Diseases

    Mastocytosis – Trials in Disease Hairy cell leukaemia Alexander disease – Life with Disease Phenylketonuria – Life with Disease Marginal zone lymphoma refractory Proteus syndrome Shprintzen-Goldberg syndrome – Diagnostics Alternating hemiplegia of childhood – Treatment VEXAS syndrome – Treatment Mucous membrane pemphigoid – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Star-0215 Azacitidine Sparsentan Clodronate Disodium Cemdisiran L-ARGININE Amifostine Thiol Regadenoson Vosilasarm Venlafaxine GOLD SODIUM THIOSULFATE Bay 2927088 Magnesium Oxide, Light Vigabatrin Taminadenant Zinc Acexamate Vancomycin Hydrochloride VTX2735 SODIUM Estradiol Valerate Pamapimod More therapies…

    Learn about Your Condition

    Peripheral artery stenosis Osteonecrosis of jaw Thrombosis Invasive breast carcinoma Polyneuropathy Metastases to peritoneum Endolymphatic hydrops Migraine Acute respiratory failure Acute promyelocytic leukaemia Haemoptysis Cutaneous sarcoidosis Pancoast's tumour Addison's disease Cardiac sarcoidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on Adding OSU6162 to Treatment for Patients with Depression Resistant to SSRI/SNRI Medications

    Recruiting

    2 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • 3-(3-Methanesulfonyl-Phenyl)-1-Propyl-Piperidine Hydrochloride
    • Placebo
    Sweden

  • A Study of OSU6162 in Adults with Bipolar Depression to Evaluate Safety and Effectiveness

    Recruiting

    2 1 1
    Investigated Drugs:
    • 3-(3-Methanesulfonyl-Phenyl)-1-Propyl-Piperidine Hydrochloride
    Sweden

  • Study on the Effects of Cariprazine on Cognitive Function in Schizophrenia Patients Needing Antipsychotic Treatment Adjustment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Cariprazine
    Austria

  • Study on Ketamine and Midazolam for Treating Obsessive-Compulsive Disorder in Adults

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obsessive-compulsive disorder
    Investigated Drugs:
    • Ketamine
    • Midazolam Hydrochloride
    Austria

  • Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

    Recruiting

    2 1
    Investigated Drugs:
    • Iti-1284
    Bulgaria Czechia Finland Poland Slovakia

  • Study of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Psychotic disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Belgium Bulgaria Croatia France Germany Greece +7
Previous Page
1 … 18 19 20 21 22 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!